A flow cytometry-based protocol for syngenic isolation of neurovascular unit cells from mouse and human tissues

D Spitzer, MI Khel, T Pütz, J Zinke, X Jia, K Sommer… - Nature …, 2023 - nature.com
The neurovascular unit (NVU), composed of endothelial cells, pericytes, juxtaposed
astrocytes and microglia together with neurons, is essential for proper central nervous …

Metabotropic glutamate receptors in cancer

JY Lumeng, BA Wall, J Wangari-Talbot, S Chen - Neuropharmacology, 2017 - Elsevier
Metabotropic glutamate receptors (mGluRs) are widely known for their roles in synaptic
signaling. However, accumulating evidence suggests roles of mGluRs in human …

PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting

L Ciuffreda, I Falcone, UC Incani, A Del Curatolo… - Advances in biological …, 2014 - Elsevier
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a non-redundant
lipid phosphatase that restrains and fine tunes the phosphatidylinositol-3-kinase (PI3K) …

Effective treatment of metastatic melanoma by combining MAPK and PI3K signaling pathway inhibitors

S Nymark Aasen, H Parajuli, T Hoang, Z Feng… - International journal of …, 2019 - mdpi.com
Malignant melanoma is the most aggressive type of skin cancer and is closely associated
with the development of brain metastases. Despite aggressive treatment, the prognosis has …

Platelet-derived extracellular vesicles induced through different activation pathways drive melanoma progression by functional and transcriptional changes

Z Tavukcuoglu, U Butt, AVS de Faria… - Cell Communication and …, 2024 - Springer
Background Beyond their conventional roles in hemostasis and wound healing, platelets
have been shown to facilitate hematogenous metastasis by interacting with cancer cells …

The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt …

S Candido, R Salemi, S Piccinin, L Falzone, M Libra - Pharmaceutics, 2022 - mdpi.com
The targeting of the Mitogen-Activated Protein Kinase (MAPK) signalling pathway in
melanoma improves the prognosis of patients harbouring the V-Raf Murine Sarcoma Viral …

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

M Milella, I Falcone, F Conciatori, S Matteoni… - Scientific reports, 2017 - nature.com
Abstract Combined MAPK/PI3K pathway inhibition represents an attractive, albeit toxic,
therapeutic strategy in oncology. Since PTEN lies at the intersection of these two pathways …

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma

J Liu, Z Zhou, L Ma, C Li, Y Lin, T Yu, JF Wei… - Cancer Cell …, 2021 - Springer
Background Melanoma is an extremely aggressive type of skin cancer and experiencing a
expeditiously rising mortality in a current year. Exploring new potential prognostic …

Emerging findings into molecular mechanism of brain metastasis

W Ni, W Chen, Y Lu - Cancer medicine, 2018 - Wiley Online Library
Brain metastasis is an important cause of morbidity and mortality in cancer patients. Hence,
the need to develop improved therapies to prevent and treat metastasis to the brain is …

The mTOR signaling pathway as a treatment target for intracranial neoplasms

D Pachow, W Wick, DH Gutmann, C Mawrin - Neuro-oncology, 2015 - academic.oup.com
Inhibition of the mammalian target of rapamycin (mTOR) signaling pathway has become an
attractive target for human cancer therapy. Hyperactivation of mTOR has been reported in …